Azimilide reduced the incidence of atrial fibrillation (AF) but had no effect on mortality in patients with left ventricular dysfunction after recent myocardial infarction

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1435, 2004-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Valsartan: A Review of its Use in Patients with Heart Failure and/or Left Ventricular Systolic Dysfunction After Myocardial Infarction

By Katherine F. Croom   Gillian M. Keating  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 6, 2004-01 ,pp. : 395-404

Adis International

Access to resources Recommend Favorite

Should the aldosterone-receptor antagonist – eplerenone – be used after acute myocardial infarction with left ventricular dysfunction?

By Doggrell Sheila  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 9, 2003-09 ,pp. : 1605-1607

Informa Healthcare

Access to resources Recommend Favorite

Eplerenone: A Review of its Use in Left Ventricular Systolic Dysfunction and Heart Failure After Acute Myocardial Infarction

By Gillian M. Keating   Greg L. Plosker  

Drugs, Vol. 64, Iss. 23, 2004-01 ,pp. : 2689-2707

Adis International

Access to resources Recommend Favorite

Effect of Ischaemic Postconditioning on Recovery of Left Ventricular Contractile Function after Acute Myocardial Infarction

By Zhao CM   Yang XJ   Yang JH   Cheng XJ   Zhao X   Zhou BY   Xu SD   Wang HF  

The Journal of International Medical Research, Vol. 40, Iss. 3, 2012-05 ,pp. : 1082-1088

Field House Publishing

Access to resources Recommend Favorite

Bone marrow infusion improves left ventricular function after myocardial infarction

By  

Inpharma, Vol. 1, Iss. 1561, 2006-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite